Discovery Home

Dynamix’ robust ‘drug discovery engine’ enables rapid discovery and optimization of novel drug candidates for a broad range of drug targets.

At the core of this ‘drug discovery engine’ lies our innovative in silico platform technology – DynamixFit™, which overcomes the problem of ‘induced fit’ in structure based drug design. Dynamix ‘discovery engine’ integrates DynamixFit™  with a broad range of experimental methodologies for rapid hypothesis-driven optimization of its drug candidates.

Dynamix discovery is especially suitable for identifying and developing highly selective Type II Kinase inhibitors, which are optimal agents for targeted therapy, and potent Cancel metabolism modulators.